NCT07141030View on ClinicalTrials.gov

Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

October 9, 2025

Study Completion Date

March 31, 2026

Conditions
Obesity/Overweight
Interventions
DRUG

GZR18 injection

GZR18 injection:3mg

Trial Locations (1)

Unknown

RECRUITING

Gan & Lee Pharmaceuticals, Beijing

Sponsors
All Listed Sponsors
lead

Gan & Lee Pharmaceuticals.

INDUSTRY